In addition, ATP may fuel a direct antitumor immune response by depleting Treg cells via P2X7R-mediated cytotoxicity or via stimulation of DCs, thus triggering IL-1β release and potentiating tumor antigen presentation to CD4+ and CD8+ lymphocytes [140,141,142,143] (Figure 2). The gene discussed is CD8A; the disease is neoplasm.